<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Specific Aims (Phase I)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I Specific Aims: significance, innovation, objective, central hypothesis, aims, outcomes, impact."/>
  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.45;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    /* Shared header/nav (matches index.html) */
    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }
    .section{
      max-width: 980px;
      margin: 0 auto;
      padding: 28px 20px;
    }

    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:center; justify-content:space-between;
      padding-top: 16px;
      margin-bottom: 14px;
    }
    .doc-title{
      font-size: 1.25rem;
      font-weight: 800;
      color:#f9fafb;
      margin: 0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    h2{
      font-size: .9rem;
      letter-spacing: .14em;
      text-transform: uppercase;
      color:#a5b4fc;
      margin: 18px 0 8px;
    }

    p{
      margin: 0 0 10px;
      font-size: .93rem;
      color:#d1d5db;
    }

    .box{
      margin: 10px 0 12px;
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px solid rgba(148,163,184,0.35);
      background: rgba(15,23,42,0.75);
    }
    .box strong{ color:#22c55e; }

    ul{
      margin: 6px 0 10px;
      padding-left: 1.1rem;
      color:#d1d5db;
      font-size: .92rem;
    }
    li{ margin-bottom: 4px; }

    .fine{
      font-size:.78rem;
      color:#9ca3af;
      margin-top: 10px;
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

 /* =========================
   PRINT CONFIG (SBIR PDF)
   - Website view: unchanged
   - PDF output: stable + compact
   ========================= */
@media print {
  @page { size: Letter; margin: 0.5in; }

  header, footer { display: none !important; }

  body {
    background: #fff !important;
    color: #111 !important;
    -webkit-print-color-adjust: exact;
    print-color-adjust: exact;
    line-height: 1.35;            /* <-- Aims 1-page helper */
  }

  p, li, h1, h2, h3 { color: #111 !important; }

  .section { max-width: 100% !important; padding: 0 !important; }

  /* If you use .box cards */
  .box { border: 1px solid #999 !important; background: #fff !important; }

  /* Tighten lists slightly (helps 1-page without deleting text) */
  ul { margin-top: 4px !important; margin-bottom: 4px !important; }
  li { margin-bottom: 3px !important; }

  /* Avoid awkward splits */
  h1, h2, h3, p, ul, li, .box, .callout, .card {
    break-inside: avoid;
    page-break-inside: avoid;
  }
}


    body {
      -webkit-print-color-adjust: exact;
      print-color-adjust: exact;
    }

    h1, h2, h3, p, ul, li, .card, .callout {
      break-inside: avoid;
      page-break-inside: avoid;
    }
  }  
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html" class="active">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">Specific Aims (Phase I): PromptGenix – BioAI Automation Platform</h1>
        <div class="meta">
          PromptGenix LLC (Women &amp; Minority-Owned) &middot; Contact: dohoon.kim1@icloud.com &middot;
          Website: promptgenix.org/sbir.html
        </div>
      </div>

      <h2>Significance</h2>
      <p>
        Immunology and infectious disease programs generate large volumes of RNA-Seq, single-cell RNA-Seq,
        and high-dimensional flow cytometry data, yet analysis often depends on fragmented tools, custom scripts,
        and scarce expert time. This drives long turnaround, inconsistent reproducibility, and delayed biological interpretation.
      </p>
      <p>
        The bottleneck is not only computation, but scientific synthesis: translating multi-omic outputs into
        actionable mechanisms, experiment plans, and study decisions.
      </p>

      <h2>Innovation</h2>
      <p>
        PromptGenix introduces an integrated BioAI co-investigator that combines end-to-end automated omics pipelines
        with an internal, literature-aware LLM layer and a <strong>Hypothesis Generator</strong>.
        Instead of producing only static plots and summaries, PromptGenix ranks mechanistic hypotheses and proposes
        concrete follow-up experiments grounded in traceable PubMed-aware reasoning.
      </p>

      <h2>Overall objective &amp; central hypothesis</h2>
      <div class="box">
        <p><strong>Objective:</strong> Deliver a validated, reproducible Phase I prototype that automates RNA-Seq and flow cytometry workflows
          and generates reviewer-ready reports with ranked hypotheses and suggested validation experiments.</p>
        <p><strong>Central hypothesis:</strong> Standardized automated pipelines combined with traceable, literature-aware LLM reasoning
          will reduce analysis turnaround time and increase interpretability, enabling faster, higher-quality study decisions
          in immunology and infectious disease research.</p>
      </div>

      <h2>Specific aims</h2>
      <ul>
        <li><strong>Aim 1.</strong> Harden end-to-end automated RNA-Seq and flow cytometry pipelines using public datasets (GEO, SRA, FlowRepository).</li>
        <li><strong>Aim 2.</strong> Implement a traceable Hypothesis Generator that ranks biological hypotheses and proposes validation experiments with PubMed-aware citations.</li>
        <li><strong>Aim 3.</strong> Generate exportable HTML/PDF reports and evaluate usability through 2–3 pilot studies using public or de-identified datasets.</li>
      </ul>

      <h2>Expected outcomes &amp; deliverables</h2>
      <ul>
        <li>Validated prototype producing reproducible outputs across reruns (versioned configs + reports).</li>
        <li>Reviewer-ready reports generated within &lt;24 hours from raw data inputs (dataset-dependent).</li>
        <li>Measured reductions in turnaround time and positive user feedback on AI-generated hypotheses.</li>
      </ul>

      <h2>Impact</h2>
      <p>
        Successful completion of Phase I will establish PromptGenix as a scalable BioAI co-investigator platform for
        immunology studies. Phase I validation will rely exclusively on public datasets to avoid IP/data-use conflicts,
        positioning the platform for Phase II expansion into multi-site studies and secure deployments.
      </p>

      <div class="fine">
        Phase I SBIR – NIH/NIAID focus &middot; Public-data validation &middot; Women &amp; Minority-Owned Small Business
      </div>
    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot;
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
